Secondaries announced 01.18.2017

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Heron Therapeutics
Symbol: HRTX
Price: Last trade $12.80
Description: Re-offer range $12.00-$12.30
Trade Date: 1/19
Shares: 11.7 million
Underwriter(s)BofA Merrill Lynch, Cowen, Leerink
Rating=Subscription Needed

Company: Apollo Global Management-BLOCK
Symbol: APO
Price: Last trade $21.20
Description: Re-offer $20.70-$20.90
Trade Date: 1/19
Shares: 5 million
Underwriter(s)Morgan Stanley
Rating=Subscription Needed

Company: Viper Energy Partners LP
Symbol: VNOM
Price: Last trade $16.72
Description: Re-offer $15.20-$15.70
Trade Date: 1/19
Shares: 7 million
Underwriter(s)Credit Suisse, Citigroup, UBS
Rating=Subscription Needed

Company: Zynerba Pharmaceuticals, Inc.
Symbol: ZYNE
Price: Last trade $22.46
Description: Re-offer $18.00-$19.00
Trade Date: 1/19
Shares: 1.8 million
Underwriter(s)Jefferies, Piper Jaffray
Rating=Subscription Needed